ArticlePacing and clinical electrophysiology : PACE2020
Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping.
Article in Pacing and clinical electrophysiology : PACE, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed, 8 citations in OpenAlex.
- Long-Term Complications Related to Cardiac Implantable Electronic Devices.Journal of clinical medicine · 2025Review
- The Subcutaneous Implantable Cardioverter-Defibrillator: A Patient Perspective.Journal of clinical medicine · 2023Article
- Treatment and Prevention of Cardiovascular Implantable Electronic Device (CIED) Infections.CJC open · 2022Review
- Cardiac Implantable Electronic Devices Infection Assessment, Diagnosis and Management: A Review of the Literature.Journal of clinical medicine · 2022Review
- Review
- Process mapping strategies to prevent subcutaneous implantable cardioverter-defibrillator infections.Journal of cardiovascular electrophysiology · 2022Review
- Diagnosis and management of subcutaneous implantable cardioverter-defibrillator infections based on process mapping.Pacing and clinical electrophysiology : PACE · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors at 11 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundInfection is a well-recognized complication of cardiovascular implantable electronic device (CIED) implantation, including the more recently available subcutaneous implantable cardioverter-defibrillator (S-ICD). Although the AHA/ACC/HRS guidelines include recommendations for S-ICD use, currently there are no clinical trial data that address the diagnosis and management of S-ICD infections. Therefore, an expert panel was convened to develop consensus on these topics.
methodsA process mapping methodology was used to achieve a primary goal - the development of consensus on the diagnosis and management of S-ICD infections. Two face-to-face meetings of panel experts were conducted to recommend useful information to clinicians in individual patient management of S-ICD infections.
resultsPanel consensus of a stepwise approach in the diagnosis and management was developed to provide guidance in individual patient management.
conclusionAchieving expert panel consensus by process mapping methodology in S-ICD infection diagnosis and management was attainable, and the results should be helpful in individual patient management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.